Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
Revenue ContractionContracting
Percentile Rank33
3Y CAGR-29.1%
5Y CAGR+17.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-29.1%/yr
Annual compound
5Y CAGR
+17.3%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$170.16M-25.1%
2024$227.04M-9.7%
2023$251.46M-47.4%
2022$477.71M+52.2%
2021$313.84M+309.4%
2020$76.66M+41.5%
2019$54.18M-